QQQ na na (na)
DIA na na (na)
SPY na na (na)
TLT na na (na)
GLD na na (na)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-globus-medical-raises-price-target-to-77

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $75 to $77.

 barclays-maintains-overweight-on-globus-medical-raises-price-target-to-93

Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $85 to ...

 rbc-capital-maintains-outperform-on-globus-medical-raises-price-target-to-78

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $76...

 truist-securities-maintains-hold-on-globus-medical-raises-price-target-to-79

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Hold and raises the price target from...

 wells-fargo-upgrades-globus-medical-to-overweight-raises-price-target-to-78

Wells Fargo analyst Vik Chopra upgrades Globus Medical (NYSE:GMED) from Equal-Weight to Overweight and raises the price targ...

 needham-reiterates-hold-on-globus-medical

Needham analyst David Saxon reiterates Globus Medical (NYSE:GMED) with a Hold.

 globus-medical-q2-2024-adj-eps-075-beats-068-estimate-sales-629700m-beat-615345m-estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.68 by...

 globus-medical-receives-fda-510k-clearance-for-excelsiusflex-and-actify-3d-total-knee-system

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clea...

 truist-securities-maintains-hold-on-globus-medical-raises-price-target-to-78

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Hold and raises the price target from...

 btig-maintains-buy-on-globus-medical-raises-price-target-to-75

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $72 to $75.

 morgan-stanley-maintains-equal-weight-on-globus-medical-raises-price-target-to-71

Morgan Stanley analyst Drew Ranieri maintains Globus Medical (NYSE:GMED) with a Equal-Weight and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION